Cargando…

Real-world experience of arbidol for Omicron variant of SARS-CoV-2

BACKGROUND: At a crucial time with the rapid spread of Omicron severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus variant globally, we conducted a study to evaluate the efficacy and safety of arbidol tablets in the treatment of this variant. METHODS: From Mar 26 to April 26, 2022, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jingya, Li, Yong, Chen, Rong, Xu, Yanping, Yang, Qingyuan, Zhang, Haiqing, Yin, Zhengxin, Gu, Weiting, Hu, Jinsong, Chen, Li, Li, Jian, Ning, Guang, Cheng, Qijian, Zhou, Min, Qu, Jieming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992600/ https://www.ncbi.nlm.nih.gov/pubmed/36910077 http://dx.doi.org/10.21037/jtd-22-980

Ejemplares similares

A trial of arbidol hydrochloride in adults with COVID-19
por: Zhao, Jingya, et al.
Publicado: (2022)

Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)

Glycomic Analysis Reveals That Sialyltransferase Inhibition Is Involved in the Antiviral Effects of Arbidol
por: Kang, Yue, et al.
Publicado: (2022)

Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
por: Yang, Chunguang, et al.
Publicado: (2020)

The Antiviral Drug Arbidol Inhibits Zika Virus
por: Fink, Susan L., et al.
Publicado: (2018)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Arbidol: The current demand, strategies, and antiviral mechanisms
por: Kang, Yue, et al.
Publicado: (2023)

Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
por: Li, Hailong, et al.
Publicado: (2021)

Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
por: Zhu, Zhen, et al.
Publicado: (2020)

Beneficial effect of Arbidol in the management of COVID-19 infection
por: Jie, Xiong, et al.
Publicado: (2021)

Synthesis and biological activity of water-soluble polymer complexes of arbidol
por: Eropkin, M. Yu., et al.
Publicado: (2010)

Efficacy of arbidol in COVID-19 patients: A retrospective study
por: Wei, Shuo, et al.
Publicado: (2021)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
por: Chen, Benjamin, et al.
Publicado: (2023)

Fighting Omicron epidemic in China: Real-world big data from Fangcang shelter hospital during the outbreak in Shanghai 2022
por: Ye, Lingying, et al.
Publicado: (2022)

Real-World COVID-19 Vaccine Protection Rates against Infection in the Delta and Omicron Eras
por: Zhu, Yuru, et al.
Publicado: (2023)

Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol
por: Teissier, Elodie, et al.
Publicado: (2011)

Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
por: Nojomi, Marzieh, et al.
Publicado: (2020)

Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
por: Eventova, Varvara A., et al.
Publicado: (2023)

COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness
por: Kherabi, Yousra, et al.
Publicado: (2022)

Hemagglutinin Stability Determines Influenza A Virus Susceptibility to a Broad-Spectrum Fusion Inhibitor Arbidol
por: Li, Zhenyu, et al.
Publicado: (2022)

The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
por: Wang, Xi, et al.
Publicado: (2020)

Pharmacokinetic interactions between the potential COVID-19 treatment drugs lopinavir/ritonavir and arbidol in rats
por: HU, Yunzhen, et al.
Publicado: (2021)

Safety of protease inhibitors and Arbidol for SARS-CoV-2 pneumonia in Zhejiang Province, China
por: Guo, Yong-zheng, et al.
Publicado: (2020)

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
por: Boriskin, Yury S, et al.
Publicado: (2006)

The Location of the Protonated and Unprotonated Forms of Arbidol in the Membrane: A Molecular Dynamics Study
por: Galiano, Vicente, et al.
Publicado: (2016)

Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo
por: Zhong, Qiong, et al.
Publicado: (2009)

The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
por: Du, Qiuling, et al.
Publicado: (2019)

Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases
por: Bai, Xinfeng, et al.
Publicado: (2023)

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
por: Li, Yueping, et al.
Publicado: (2020)

Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
por: Fang, Jie, et al.
Publicado: (2020)

World Facing the latest variant of Concern---------Omicron
por: Javaid, Muhammad Mohsin, et al.
Publicado: (2022)

Abnormalities of the Amygdala in schizophrenia: a real world study
por: Zheng, Guangen, et al.
Publicado: (2023)

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019
por: Wang, Xuemei, et al.
Publicado: (2020)

Effect of solvent type and concentration on size and morphology of arbidol microparticles obtained by supercritical antisolvent precipitation
por: Vorobei, A. M., et al.
Publicado: (2017)

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Amani, Behnam, et al.
Publicado: (2021)

Effect of umifenovir (arbidol) versus standard care on clinical outcome in patients with COVID-19: a retrospective cohort study
por: Yi, Wanwan, et al.
Publicado: (2023)

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
por: Weil, Clara, et al.
Publicado: (2023)

Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
por: Yin, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mdu11cg7c2kak8etg1cm4djo06